Methodology
Bounded Health operates using evidence-based methodologies for GLP-1 cost containment. Our approach is designed for predictability, safety, and institutional accountability.
Clinical Tapering Framework
Our tapering methodology is based on established deprescribing principles from clinical literature. Dose reduction follows gradual, monitored protocols with defined metabolic stability checkpoints. Protocols are conservative and prioritize member safety over cost reduction velocity.
Risk Stratification
Members are stratified into risk cohorts based on metabolic stability, adherence history, comorbidity burden, and behavioral indicators. Only members meeting conservative stability thresholds are candidates for tapering protocols.
Outcome Measurement
Outcomes are measured using cost reduction (realized pharmacy spend savings), clinical safety (adverse event rates, metabolic decompensation), and member satisfaction. Projections include confidence intervals and are reported conservatively.
Continuous Calibration
Prediction models are continuously calibrated against actual outcomes. When model predictions diverge from observed results, recalibration occurs automatically. Model performance metrics are included in quarterly institutional reporting.
Transparency & Documentation
All methodological assumptions, model parameters, and decision thresholds are documented and available to institutional partners. Methodology documentation is maintained in version-controlled registries for audit purposes.
Methodology Inquiries
For detailed methodology documentation, model validation reports, or research collaboration.